Visiting Professor Lecture Video Series

The Taubman Institute collaborates with other University of Michigan Medical School departments to invite distinguished thought leaders in medical research to speak on the U-M campus in Ann Arbor. These Visiting Professor Lectures are generally held monthly and represent the Taubman Institute's ongoing commitment to furthering translational medical research by creating opportunities for the most talented physician-researchers to exchange knowledge and ideas.

Now, we’ve instituted a video series so that outreach can extend to the lay and scientific communities beyond Ann Arbor. In each video, the U-M host faculty member interviews the visiting professor about the highlights of his or her talk.

Dr. Joshua Hare of the University of Miami Miller School of Medicine discusses the clinical trial of a stem cell therapy for people whose heart tissue has been scarred. 

Dr. David Kirsch of Duke University Medical College discusses the use of mouse models to study the effects of radiation therapy for cancer.

Dr. A. Gordon Smith of the University of Utah School of Medicine discusses new research and treatment models for the study of diabetic neuropathy.

Dr. Kurt Stenmark, professor of pediatrics at the University of Colorado, discusses his research into pulmonary hypertension with Taubman Scholar Dr. Valerie Castle, chair of the U-M Health System's department of pediatrics and communicable diseases.

Dr. Andrew Mammen, associate professor of neurology at and medicine at the Johns Hopkins University School of Medicine, discusses his research into autoimmune muscle disease with Dr. Eva Feldman, the Russell N. DeJong professor of neurology at the University of Michigan Medical School and director of the A. Alfred Taubman Medical Research Institute.

Dr. Steven Ringel, professor of neurology at the University of Colorado, discusses issues in health care delivery with Dr. Eva Feldman, the Russell N. DeJong professor of neurology at the University of Michigan Medical School and director of the A. Alfred Taubman Medical Research Institute.

Visiting Professors Series - Sally Temple, Ph.D. and Jeffery Stern, M.D., Ph.D.


Help Us Make A Difference. Make A Donation That Could Save Lives.

Make A Gift


Follow Us / Friend Us

Discovery-driven research that matters


Taubman Scholar Dr. Charles Burant tests promising diabetes drug

TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study.

Read more

Taubman Institute leaders make the case for more doctor-scientist funding


The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts.

The article explores the problematic gap between bench research and clinical application of new treatments or cures. 

Read more

Help Us Make A Difference. Make A Gift.

Leaders from the realms of business, academia and the community help to refine the Taubman Institute's vision, to monitor progress and to provide support, advice and counsel.

Meet the Leadership Advisory Board

Meet the Scientific Advisory Board

About Taubman Institute Video

In this video feature, Taubman Scholars explain why funding for high-risk research is so important to their work and to the discovery of promising cures and treatments.  


Stem cell surgery targets ALS Video

Patients glean hope from trial’s progress but wish it were faster


video-emerging-scholars-programDonors pitch in to keep brilliant science minds at U-M Video

Emerging Scholars program connects promising M.D.-researchers with philanthropists